Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...

Sharni Marks, 31, was added to the waiting list in August 2022 without a specified surgery date. Despite being repeatedly informed she was a priority for the operation, it wasn't until March 2024 that ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...